These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27176560)

  • 1. A novel nonviral gene delivery tool of BMP-2 for the reconstitution of critical-size bone defects in rats.
    Kolk A; Tischer T; Koch C; Vogt S; Haller B; Smeets R; Kreutzer K; Plank C; Bissinger O
    J Biomed Mater Res A; 2016 Oct; 104(10):2441-55. PubMed ID: 27176560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of bioactivated and antiinfective PDLLA - coated surfaces.
    Haidari S; Boskov M; Schillinger U; Bissinger O; Wolff KD; Plank C; Kolk A
    J Biomed Mater Res A; 2017 Jun; 105(6):1672-1683. PubMed ID: 28218496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of bone regeneration behavior using recombinant human BMP-2 versus plasmid DNA of BMP-2.
    Kolk A; Boskov M; Haidari S; Tischer T; van Griensven M; Bissinger O; Plank C
    J Biomed Mater Res A; 2019 Jan; 107(1):163-173. PubMed ID: 30358084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes.
    Park J; Ries J; Gelse K; Kloss F; von der Mark K; Wiltfang J; Neukam FW; Schneider H
    Gene Ther; 2003 Jul; 10(13):1089-98. PubMed ID: 12808439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New approach for vertical bone regeneration using in situ gelling and sustained BMP-2 releasing poly(phosphazene) hydrogel system on peri-implant site with critical defect in a canine model.
    Seo BB; Chang HI; Choi H; Koh JT; Yun KD; Lee JY; Song SC
    J Biomed Mater Res B Appl Biomater; 2018 Feb; 106(2):751-759. PubMed ID: 28334520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone response to the multilayer BMP-2 gene coated porous titanium implant surface.
    Jiang QH; Liu L; Peel S; Yang GL; Zhao SF; He FM
    Clin Oral Implants Res; 2013 Aug; 24(8):853-61. PubMed ID: 22168601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo bone morphogenetic protein-2 gene delivery using gingival fibroblasts promotes bone regeneration in rats.
    Shin JH; Kim KH; Kim SH; Koo KT; Kim TI; Seol YJ; Ku Y; Rhyu IC; Chung CP; Lee YM
    J Clin Periodontol; 2010 Mar; 37(3):305-11. PubMed ID: 20041973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental pilot study on surface activation of implants with liposomal vectors].
    Thorwarth M; Schlegel KA; Wiltfang J; Rupprecht S; Park JH
    Mund Kiefer Gesichtschir; 2004 Jul; 8(4):250-5. PubMed ID: 15293121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone regeneration after topical BMP-2-gene delivery in circumferential peri-implant bone defects.
    Lutz R; Park J; Felszeghy E; Wiltfang J; Nkenke E; Schlegel KA
    Clin Oral Implants Res; 2008 Jun; 19(6):590-9. PubMed ID: 18422983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstruction of mandibular bone defects using biphasic calcium phosphate bone substitutes with simultaneous implant placement in mini-swine: A pilot in vivo study.
    Zhang Z; Wang P; Li X; Wang Y; Qin Z; Zhang C; Li J
    J Biomed Mater Res B Appl Biomater; 2019 Aug; 107(6):2071-2079. PubMed ID: 30576059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The enhancement of osteogenic capacity in a synthetic BMP-2 derived peptide coated mineralized collagen composite in the treatment of the mandibular defects.
    Zhang L; Mu W; Chen S; Yang D; Xu F; Wu Y
    Biomed Mater Eng; 2016 Nov; 27(5):495-505. PubMed ID: 27885997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced bone regeneration of cortical segmental bone defects using porous titanium scaffolds incorporated with colloidal gelatin gels for time- and dose-controlled delivery of dual growth factors.
    van der Stok J; Wang H; Amin Yavari S; Siebelt M; Sandker M; Waarsing JH; Verhaar JA; Jahr H; Zadpoor AA; Leeuwenburgh SC; Weinans H
    Tissue Eng Part A; 2013 Dec; 19(23-24):2605-14. PubMed ID: 23822814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect on bone regeneration of a liposomal vector to deliver BMP-2 gene to bone grafts in peri-implant bone defects.
    Park J; Lutz R; Felszeghy E; Wiltfang J; Nkenke E; Neukam FW; Schlegel KA
    Biomaterials; 2007 Jun; 28(17):2772-82. PubMed ID: 17339051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyapatite nanowires modified polylactic acid membrane plays barrier/osteoinduction dual roles and promotes bone regeneration in a rat mandible defect model.
    Han J; Ma B; Liu H; Wang T; Wang F; Xie C; Li M; Liu H; Ge S
    J Biomed Mater Res A; 2018 Dec; 106(12):3099-3110. PubMed ID: 30325096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A strategy to establish a gene-activated matrix on titanium using gene vectors protected in a polylactide coating.
    Kolk A; Haczek C; Koch C; Vogt S; Kullmer M; Pautke C; Deppe H; Plank C
    Biomaterials; 2011 Oct; 32(28):6850-9. PubMed ID: 21741701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteointegration of hydroxyapatite-titanium implants coated with nonglycosylated recombinant human bone morphogenetic protein-2 (BMP-2) in aged sheep.
    Sachse A; Wagner A; Keller M; Wagner O; Wetzel WD; Layher F; Venbrocks RA; Hortschansky P; Pietraszczyk M; Wiederanders B; Hempel HJ; Bossert J; Horn J; Schmuck K; Mollenhauer J
    Bone; 2005 Nov; 37(5):699-710. PubMed ID: 16139577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Improved osseointegration of titanium implants of different surface characteristics by the use of bone morphogenetic protein (BMP-3): an animal study performed at the metaphyseal bone bed in dogs].
    Hartwig CH; Esenwein SA; Pfund A; Küsswetter Dagger W; Herr G
    Z Orthop Ihre Grenzgeb; 2003; 141(6):705-11. PubMed ID: 14679438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of implants coated with recombinant human bone morphogenetic protein-2 and vacuum-dried using the critical-size supraalveolar peri-implant defect model in dogs.
    Decker JF; Lee J; Cortella CA; Polimeni G; Rohrer MD; Wozney JM; Hall J; Susin C; Wikesjö UM
    J Periodontol; 2010 Dec; 81(12):1839-49. PubMed ID: 20629551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects.
    Boyne PJ
    J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S146-50. PubMed ID: 11314792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healing of large segmental bone defects induced by expedited bone morphogenetic protein-2 gene-activated, syngeneic muscle grafts.
    Betz OB; Betz VM; Abdulazim A; Penzkofer R; Schmitt B; Schröder C; Augat P; Jansson V; Müller PE
    Hum Gene Ther; 2009 Dec; 20(12):1589-96. PubMed ID: 19572783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.